Empagliflozin vs Sitagliptin vs Metformin in Type 2 Diabetes: A Small Three-Arm Trial
A small randomized three-arm trial comparing empagliflozin, sitagliptin, and metformin on glycemic and cardio-metabolic parameters in type 2 diabetes, with significance shown mainly against the metformin arm. PICO summary and expert commentary.
